Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.48 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | HCAR3 | P49019 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL295430 | 1.00 | CRHBP (0.48) | CRHBPCRHR2DGAT1MAPTALDH1A1 | |
| SCHEMBL29395468 | 1.00 | CRHBP (0.48) | CRHBPCRHR2DGAT1MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL19970925 | 0.99 | CRHBP (0.47) | CRHBPCRHR2DGAT1MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL19970924 | 0.99 | CRHBP (0.47) | CRHBPCRHR2DGAT1MAPTALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL29659178 | 0.94 | POLB (0.44) | CRHBPCRHR2DGAT1MAPTALDH1A1 | |
| SCHEMBL4295081 | 0.87 | CRHBP (0.50) | CRHBPCRHR2DGAT1MAPTALDH1A1 | |
| SCHEMBL26496459 | 0.87 | ALDH1A1 (0.56) | CRHBPCRHR2DGAT1MAPTALDH1A1 | |
| SCHEMBL1875530 | 0.87 | CRHBP (0.52) | CRHBPCRHR2MAPTALDH1A1KDM4E | |
| SCHEMBL1875534 | 0.87 | CRHBP (0.52) | CRHBPCRHR2MAPTALDH1A1KDM4E | |
| SCHEMBL10419285 | 0.85 | NPC1 (0.52) | CRHBPCRHR2DGAT1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287383-A1 | PYRROLYSYL-tRNA SYNTHETASE VARIANTS AND USES THEREOF | ENGENES BIOTECH GMBH (AT) | 2023-09-14 | — | — | US | claimed |
| US-20250320181-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | ARTIZAN BIOSCIENCES INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | BAYER AKTIENGESELLSCHAFT (DE) | 2025-08-26 | — | — | US | disclosed |
| US-20240425450-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. | 2024-12-26 | — | — | US | disclosed |
| EP-4405330-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| EP-4058448-B1 | HYDANTOIN DERIVATIVES AS ADAMTS7 ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER AG (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-20230357139-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. | 2023-11-09 | — | — | US | disclosed |
| US-20230287383-A1 | PYRROLYSYL-tRNA SYNTHETASE VARIANTS AND USES THEREOF | ENGENES BIOTECH GMBH (AT) | 2023-09-14 | — | — | US | disclosed |
| WO-2023049785-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. (US) | 2023-03-30 | — | — | WO | disclosed |
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | US | disclosed |
| CN-101932936-A | Resonance energy transfer assay using cleavage sequence and spacer | BIOSENTINEL LLC | 2010-12-29 | — | — | CN | disclosed |
| EP-2208067-A1 | RESONANCE ENERGY TRANSFER ASSAY WITH CLEAVAGE SEQUENCE AND SPACER | Biosentinel, LLC (US) | 2010-07-21 | — | — | EP | disclosed |
| US-20090240040-A1 | PURIFICATION OF A BIVALENTLY ACTIVE ANTIBODY USING A NON-CHROMATOGRAPHIC METHOD | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-09-24 | — | — | US | disclosed |
| EP-2049570-A2 | PURIFICATION OF A BIVALENTLY ACTIVE ANTIBODY USING A NON-CHROMATOGRAPHIC METHOD | President and Fellows of Harvard College (US) | 2009-04-22 | — | — | EP | disclosed |
| WO-2009035476-A1 | RESONANCE ENERGY TRANSFER ASSAY WITH CLEAVAGE SEQUENCE AND SPACER | BIOSENTINEL, LLC (US) | 2009-03-19 | — | — | WO | disclosed |
| WO-2007143121-A2 | PURIFICATION OF A BIVALENTLY ACTIVE ANTIBODY USING A NON-CHROMATOGRAPHIC METHOD | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-12-13 | — | — | WO | disclosed |
| EP-1751284-A2 | METHOD AND COMPOSITIONS FOR DETECTING BOTULINUM NEUROTOXIN | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2007-02-14 | — | — | EP | disclosed |
| US-20060134722-A1 | Method and compositions for detecting botulinum neurotoxin | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2006-06-22 | — | — | US | disclosed |
| WO-2005076785-A2 | METHOD AND COMPOSITIONS FOR DETECTING BOTULINUM NEUROTOXIN | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-08-25 | — | — | WO | disclosed |
| US-6504006-B1 | Detecting and measuring the proteolytic activity of botulium type A neurotoxin in an assay are described. Detection is based on an increase in fluorescence due to hydrolysis of these internally quenched fluorescent peptide substrates by | LIST BIOLOGICAL LABORATORIES, INC. | 2003-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357139-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | FABP2, APC, SI | CRHBP 2383/4885CRHR2 4716/4885DGAT1 3050/4885 |
| US-20250320181-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | FABP2, APC, STMN1 | CRHBP 2247/4885CRHR2 4787/4885DGAT1 4077/4885 |
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | ADAMTS7, MMP7, ADAM17 | CRHBP 1830/4885CRHR2 497/4885DGAT1 4458/4885 |
| US-20240425450-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | FABP2, APC, SI | CRHBP 2383/4885CRHR2 4716/4885DGAT1 3050/4885 |
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | ADAMTS7, MMP7, ADAM17 | CRHBP 1830/4885CRHR2 497/4885DGAT1 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.